Diagnostic Accuracy of FOBT and Colorectal Cancer Genetic Testing: A Systematic Review & Meta-Analysis
References
- World Health Organization (WHO). Cancer; fact sheet no 297 2014. Available from:
http://www.who.int/medacentre/factsheets/fs297/en . - American Cancer Society. Colorectal Cancer Facts & Figures 2011–2013; 2013.
- Sung JJ, Ng SC, Chan FK, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015; 64(1): 121–32. DOI: 10.1136/gutjnl-2013-306503
- Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate- and high-risk groups (update from 2002). Gut. 2010; 59(5): 666–89. DOI: 10.1136/gut.2009.179804
- Ministry of Health.
Clinical Guidelines Practice: Management of Colorectal Cancer . Malaysia Health Technology Assessment Section (MaHTAS) 2017. - Von Karsa L, Patnick J, Segnan N, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication. Endoscopy. 2013; 45(1): 51–9. DOI: 10.1055/s-0032-1325997
- Whitlock EP, Lin JS, Liles E, Beil TL and Fu R. Screening for colorectal cancer: A targeted, updated systematic review for the U.S. Preventive Services Task Force. Annals of internal medicine. 2008; 149(9): 638–58. DOI: 10.7326/0003-4819-149-9-200811040-00245
- Qaseem A, Denberg TD, Hopkins RH, et al. Screening for colorectal cancer: A guidance statement from the American College of Physicians. Annals of internal medicine. 2012; 156(5): 378–86. DOI: 10.7326/0003-4819-156-5-201203060-00010
- Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA and Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. The American journal of gastroenterology. 2009; 104(3): 739–50. DOI: 10.1038/ajg.2009.104
- Lin JS, Piper MA, Perdue LA, et al. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Jama. 2016; 315(23): 2576–94. DOI: 10.1001/jama.2016.3332
- Zhu MM, Xu XT, Nie F, Tong JL, Xiao SD and Ran ZH. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta-analysis. Journal of digestive diseases. 2010; 11(3): 148–60. DOI: 10.1111/j.1751-2980.2010.00430.x
- Hewitson P, Glasziou P, Irwig L, Towler B and Watson E. Screening for colorectal cancer using the fecal occult blood test, Hemoccult. The Cochrane database of systematic reviews. 2007; 1:
Cd001216 . DOI: 10.1002/14651858.CD001216.pub2 - Ministry of Health. Health Technology Assessment Section (MaHTAS) MDD, Ministry of Health Malaysia. Immunochemical Faecal Occult Blood Test (IFOBT) For Colorectal Cancer (CRC) Screening. MOH/P/PAK/233. 12(TR). 2011.
- Fuzi SAM, Sabirin J and Hussain S. Health Technology Assessment Report- Immunochemical Fecal Occult Blood Test (IFOBT) For Colorectal Cancer (CRC) Screening; 2012.
- Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: A cancer journal for clinicians. 2008; 58(3): 130–60. DOI: 10.3322/CA.2007.0018
- Taylor DP, Burt RW, Williams MS, Haug PJ and Cannon-Albright LA. Population-based family history—specific risks for colorectal cancer: A constellation approach. Gastroenterology. 2010; 138(3): 877–85. DOI: 10.1053/j.gastro.2009.11.044
- Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Diseases of the colon and rectum. 2014; 57(8): 1025–48. DOI: 10.1097/DCR.000000000000000
- Vasen HF, Watson P, Mecklin JP and Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999; 116(6): 1453–6. DOI: 10.1016/S0016-5085(99)70510-X
- Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. Journal of the National Cancer Institute. 1997; 89(23): 1758–62. DOI: 10.1093/jnci/89.23.1758
- Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute. 2004; 96(4): 261–8. DOI: 10.1093/jnci/djh034
- Nieuwenhuis MH, Vogt S, Jones N, et al. Evidence for accelerated colorectal adenoma-carcinoma progression in MUTYH-associated polyposis? Gut. 2012; 61(5): 734–8. DOI: 10.1136/gut.2010.229104
- Kievit W, de Bruin JH, Adang EM, et al. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: A meta-analysis. Clin Genet. 2004; 65(4): 308–16. DOI: 10.1111/j.1399-0004.2004.00220.x
- Kastrinos F, Balmana J and Syngal S. Prediction models in Lynch syndrome. Fam Cancer. 2013; 12(2): 217–28. DOI: 10.1007/s10689-013-9632-0
- Griffith GL, Edwards RT and Gray J. Cancer genetics services: A systematic review of the economic evidence and issues. British journal of cancer. 2004; 90(9): 1697–703. DOI: 10.1038/sj.bjc.6601792
- Liu Z, Yao Z, Li C, et al. A step-by-step guide to the systematic review and meta-analysis of diagnostic and prognostic test accuracy evaluations. British journal of cancer. 2013; 108(11): 2299–303. DOI: 10.1038/bjc.2013.185
- Whiting P, Rutjes AWS, Reitsma JB, Bossuyt PMM and Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology. 2003; 3(1): 25. DOI: 10.1186/1471-2288-3-25
- Whiting PF, Weswood ME, Rutjes AWS, Reitsma JB, Bossuyt PNM and Kleijnen J. Evaluation of QUADAS: A tool for the quality assessment of diagnostic accuracy studies. BMC medical research methodology. 2006; 6: 9. DOI: 10.1186/1471-2288-6-9
- Hirai HW, Tsoi KK, Chan JY, et al. Systematic review with meta-analysis: Fecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies. Alimentary pharmacology & therapeutics. 2016; 43(7): 755–64. DOI: 10.1111/apt.13556
- Shapiro JA, Bobo JK, Church TR, et al. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. The American journal of gastroenterology. 2017; 112(11): 1728–35. DOI: 10.1038/ajg.2017.285
- Jucá MJ, Assuncão PRT and Hasten-Reiter Júnior HN. Fecal occult blood test and flexible rectosigmoidoscopy: Tools for the screening of colorectal neoplasms in asymptomatic patients. Journal of Coloproctology. 2015; 35(1): 35–41. DOI: 10.1016/j.jcol.2015.01.002
- Elsafi SH, Alqahtani NI, Zakary NY and Al Zahrani EM. The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings. Clinical and Experimental Gastroenterology. 2015; 8: 279–84. DOI: 10.2147/CEG.S86419
- Lohsiriwat V. Accuracy of self-checked fecal occult blood testing for colorectal cancer in Thai patients. Asian Pacific Journal of Cancer Prevention. 2014; 15(18): 7981–4. DOI: 10.7314/APJCP.2014.15.18.7981
- Redwood D, Provost E, Asay E, et al. Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska native population with high prevalence of Helicobacter pylori infection, 2008–2012. Preventing Chronic Disease. 2014; 11(4). DOI: 10.5888/pcd11.130281
- Yeasmin F, Ali M, Rahman M, Sultana T, Rahman MQ and Ahmed A. A comparative study of chemical and immunological method of fecal occult blood test in the diagnosis of occult lower gastrointestinal bleeding. Bangladesh Medical Research Council Bulletin. 2014; 39(2): 52–6. DOI: 10.3329/bmrcb.v39i2.19641
- Xie L, Jiang X, Li Q, et al. Diagnostic value of methylated Septin9 for colorectal cancer detection. Frontiers in Oncology. 2018 July; 8. DOI: 10.3389/fonc.2018.00247
- Johnson DH, Taylor WR, Aboelsoud MM, et al. DNA methylation and mutation of small colonic neoplasms in Ulcerative Colitis and Crohn’s Colitis: Implications for surveillance. Inflammatory Bowel Diseases. 2016; 22(7): 1559–67. DOI: 10.1097/MIB.0000000000000795
- Kanth P, Bronner MP, Boucher KM, et al. Gene signature in sessile serrated polyps identifies colon cancer subtype. Cancer Prevention Research. 2016; 9(6): 456–65. DOI: 10.1158/1940-6207.CAPR-15-0363
- Dvorak K, Aggeler B, Palting J, McKelvie P, Ruszkiewicz A and Waring P. Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: Impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma. Pathology. 2014; 46(6): 509–17. DOI: 10.1097/PAT.0000000000000119
- Amiot A, Mansour H, Baumgaertner I, et al. The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening. PLoS ONE. 2014; 9(7). DOI: 10.1371/journal.pone.0099233
DOI: https://doi.org/10.5334/aogh.2466 | Journal eISSN: 2214-9996
Language: English
Published on: May 15, 2019
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2019 Abdul Rahman Ramdzan, Muhammad Aklil Abd Rahim, Aznida Mohamad Zaki, Zuraidah Zaidun, Azmawati Mohammed Nawi, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.